Q: Down another 17 cents or 4.4% early at 10am. Were basically at a 52 week low. Do you think there should be a time where the regulators look into the trading at some point. Even if there was nothing nefarious I believe they could change or evolve trading in this high tech, AI enviornment. I don't want the general population to develop a feeling deception like the media got branded "fake news".
Business wise during the conference, I don't understand creating shareholder value by possibly selling Wisp or CRH medical. How would they replace all that recurring revenue.
Thanks Steve
Business wise during the conference, I don't understand creating shareholder value by possibly selling Wisp or CRH medical. How would they replace all that recurring revenue.
Thanks Steve
5i Research Answer:
Even though CRH has turned out OK, investors originally did not like the deal at all, and selling it could change sentiment/valuation multiples. If assets are sold then (perhaps) faster growing companies could be added. We get the feeling management is just mostly frustrated: many things are going right but investors are not responding. For a small cap stock, we would not see the trading as overly unusual enough to warrant any investigations.